Crinetics Pharmaceuticals
CRNX
CRNX
62 hedge funds and large institutions have $404M invested in Crinetics Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
20% less capital invested
Capital invested by funds: $503M → $404M (-$99.7M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
62
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$15.4M | |
| 2 | +$5.94M | |
| 3 | +$4.09M | |
| 4 |
BlackRock
New York
|
+$1.93M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.66M |
Top Sellers
| 1 | -$9.49M | |
| 2 | -$2.86M | |
| 3 | -$944K | |
| 4 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
-$330K |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$288K |